Cargando…
Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma
Alveolar soft part sarcoma (ASPS) is a rare soft tissue sarcoma and the clinical management of patients with unresectable, metastatic disease is still challenging. ASPS expresses an array of potentially therapeutically targetable, angiogenesis-related molecules and, importantly, it has a distinctive...
Autores principales: | Castelli, Chiara, Tazzari, Marcella, Negri, Tiziana, Vergani, Barbara, Rivoltini, Licia, Stacchiotti, Silvia, Pilotti, Silvana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856484/ https://www.ncbi.nlm.nih.gov/pubmed/24074204 http://dx.doi.org/10.1186/1479-5876-11-237 |
Ejemplares similares
-
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report
por: Tazzari, Marcella, et al.
Publicado: (2015) -
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy
por: Tazzari, M, et al.
Publicado: (2014) -
Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types
por: Tazzari, Marcella, et al.
Publicado: (2018) -
ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma
por: Tanaka, Miwa, et al.
Publicado: (2023) -
Alveolar soft part sarcoma of the forearm
por: Asokan, B., et al.
Publicado: (2017)